The government is considering allowing mothers to report side effects of routine immunizations on the U-WIN platform. This move aligns with the admission by AstraZeneca that its COVID-19 vaccine, Covishield, can rarely induce blood clots. The U-WIN platform, similar to CoWIN for COVID-19, tracks vaccinations and immunization. Currently in a pilot phase, U-WIN is expected to become the world’s largest electronic immunization system, aiming to improve vaccination coverage and reduce infant mortality. As part of the integration with Ayushman Bharat Digital Mission, healthcare providers will have access to patients’ complete health records.